Docebo (DCBO) Q4 2024 earnings summary

Executive summary

• Achieved US$220M in Annual Recurring Revenue (ARR) as of December 31, 2024, with 3,978 customers and 900+ employees across global offices.

• Early impact from three new product modules—AI Authoring, Advanced Analytics, and Communities—has been strong, strengthening competitive position and enterprise pipeline.

• Strategic focus is on transforming from an enterprise LMS to an AI-first learning platform, leveraging GenAI and agentic AI for hyper-personalized, automated, and measurable learning experiences.

• Leadership changes and internal promotions support transformation and growth strategy.

• Focused on expanding in enterprise, government, and customer experience (CX) learning markets, supported by strategic partnerships and product innovation.

Financial highlights

• Q4 2024 total revenue: $57.0M, up 16% year-over-year; subscription revenue: $54.0M, 95% of total.

• FY2024 total revenue: $216.9M, up 20% year-over-year; subscription revenue: $204.3M, 94% of total.

• Adjusted EBITDA margin for Q4 2024 was 16.7%, up from 13.2% in Q4 2023; FY2024 Adjusted EBITDA: $33.6M (15.5% margin).

• Free cash flow for FY2024: $32.3M (15% of revenue), with cumulative free cash flow of ~US$40M since 2016.

• Net income for FY2024: $26.7M ($0.88/share), up from $2.8M ($0.09/share) prior year.

Outlook and guidance

• FY2025 subscription revenue growth expected at 11.5–12.5% (or 13.0–14.0% adjusted for FX); total revenue growth 11.0–12.0% (or 12.5–13.5% adjusted for FX).

• FY2025 Adjusted EBITDA margin guidance: 18.0–19.0%.

• Expectation to achieve FedRAMP ATO status by end of Q3, enabling participation in federal contracts; current guidance does not include material federal government revenue.

• Ongoing investment in R&D (16-18% of revenue) and sales/marketing (28-32% of revenue) to drive innovation and market penetration.

• Enterprise and mid-enterprise demand remains strong, with increasing pipeline of large deals and long-term contracts.